Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9

Experimental and Therapeutic Medicine

Volumn 1, Issue 6, 2010, Pages 915-920

  Pradhan, Saurabh J ^a   Mishra, Rosalin ^a   Sharma, Priyanka ^a   Kundu, Gopal C ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Matrix metalloproteinase 9; Melanoma growth; Quercetin; Sulforaphane

Indexed keywords

GELATINASE B; QUERCETIN; SULFORAPHANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG MIXTURE; MALE; MELANOMA B16; MOUSE; NONHUMAN; TUMOR GROWTH;

EID: 78049279330     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.144     Document Type: Article

References (35)

1. Gray-Schopfer V, Wellbrock C and Marais R: Melanoma biology and new targeted therapy. Nature 445: 851-857, 2007.
2. Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H and van den Brandt PA: Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 5: 733-748, 1996.
3. Zhang SM, Hunter DJ, Rosner BA, Giovannucci EL, Colditz GA, Speizer FE and Willett WC: Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women. Cancer Epidemiol Biomarkers Prev 9: 477-485, 2000.
4. Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM and Haluska FG: Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J Clin Oncol 24: 4738-4745, 2006.
5. Musonda CA and Chipman JK: Quercetin inhibits hydrogen peroxide (H2O2)-induced NF-kappaB DNA binding activity and DNAdamage in HepG2 cells. Carcinogenesis 19: 1583-1589, 1998.
6. Avila MA, Velasco JA, Cansado J and Notario V: Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res 54: 2424-2428, 1994.
7. Vijayababu MR, Arunkumar A, Kanagaraj P, Venkataraman P, Krishnamoorthy G and Arunakaran J: Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol Cell Biochem 287: 109-116, 2006.
8. Choi S and Singh SV: Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. Cancer Res 65: 2035-2043, 2005.
9. Zhang Y, Tang L and Gonzalez V: Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol Cancer Ther 2: 1045-1052, 2003.
10. Zhang Wand Zhang F: Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of HeLa cells. Eur J Gynaecol Oncol 30: 60-64, 2009.
11. Braganhol E, Zamin LL, Canedo AD, Horn F, Tamajusuku AS, Wink MR, Salbego C and Battastini AM: Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs 17: 663-671, 2006.
12. Dashwood RH and Ho E: Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 17: 363-369, 2007.
13. Juge N, Mithen RF and Traka M: Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell Mol Life Sci 64: 1105-1127, 2007.
14. Singh AV, Xiao D, Lew KL, Dhir R and Singh SV: Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 25: 83-90, 2004.
15. Myzak MC, Tong P, Dashwood WM, Dashwood RH and Ho E: Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med 232: 227-234, 2007.
16. Thejass P and Kuttan G: Antimetastatic activity of sulforaphane. Life Sci 78: 3043-3050, 2006.
17. Parks WC, Wilson CL and Lopez-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629, 2004.
18. Shapiro SD: Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 10: 602-608, 1998.
19. Pyke C, Ralfkiaer E, Tryggvason Kand Dano K: Messenger RNAfor two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 142: 359-365, 1993.
20. Zeng ZS and Guillem JG: Colocalisation of matrix metalloproteinase-9-mRNAand protein in human colorectal cancer stromal cells. Br J Cancer 74: 1161-1167, 1996.
21. Houde M, de Bruyne G, Bracke M, Ingelman-Sundberg M, Skoglund G, Masure S, van Damme J and Opdenakker G: Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells. Int J Cancer 53: 395-400, 1993.
22. Rangaswami H, Bulbule A and Kundu GC: Nuclear factor inducing kinase plays crucial role in osteopontin induced MAPK/IKKdependent nuclear factor κB-mediated promatrix metalloproteinase-9 activation. J Biol Chem 279: 38921-38935, 2004.
23. Coussens LM, Tinkle CL, Hanahan D and Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490, 2000.
24. Muroski ME, Roycik MD, Newcomer RG, van den Steen PE, Opdenakker G, Monroe HR, Sahab ZJ and Sang QX: Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr Pharm Biotechnol 9: 34-46, 2008.
25. Ram M, Sherer Yand Shoenfeld Y: Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol 26: 299-307, 2006.
26. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ and Singh SV: Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 23: 5594-5606, 2004.
27. Behera R, Kumar V, Lohite K, Karnik S and Kundu GC: Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 31: 192-200, 2010.
28. Philip S, Bulbule A and Kundu GC: Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem 276: 44926-44935, 2001.
29. Chakraborty G, Jain S and Kundu GC: Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res 68: 152-161, 2008.
30. Jain S, Chakraborty G and Kundu GC: The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase Calpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis. Cancer Res 66: 6638-6648, 2006.
31. Philip S and Kundu GC: Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKKsignaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem 278: 14487-14497, 2003.
32. Jeong JH, An JY, Kwon YT, Rhee JG and Lee YJ: Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem 106: 73-82, 2009.
33. Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421, 2006.
34. Lin CW, Hou WC, Shen SC, Juan SH, Ko CH, Wang LM and Chen YC: Quercetin inhibition of tumor invasion via suppressing PKCδ/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 29: 1807-1815, 2008.
35. Zhang X-M, Huang S-P and Xu Q: Quercetin inhibits the invasion of murine melanoma B16BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemother Pharmacol 53: 82-88, 2004.